A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract

A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract - A clinical trial about the safety of 5 times amount intake of Chrysanthemum Morifolium Flower extract

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027214

Enrollment

Registered

2017-06-16

Start date

2017-05-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subject

Interventions

500mg/day Chrysanthemum Morifolium Flower extract supplementation (4 weeks) 500mg/day placebo supplementation (4 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy subjects, male and female, who are 20 years of age or over

Exclusion criteria

Exclusion criteria: 1) Subjects in medication, or who have anamnesis with serious disease that require medication 2) Subjects with chronic disease of asthma 3) Subjects who are allergic to the test sample

Design outcomes

Primary

Measure	Time frame
Blood test 4 weeks after intake atart	—

Secondary

Measure	Time frame
Blood pressure, pulse, urinalysis and questionnaire 4 weeks after intake start	—

Countries

Japan

Contacts

Public ContactKazuya Toda

ORYZA OIL & FAT CHEMICAL CO., LTD. Food Development Dept. R & D Center

kaihatsu@mri.biglobe.ne.jp0586865141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026